Skip to main content
Published locations for Reduced hospitalization risk with dupilumab in moderate-to-severe atopic dermatitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Reduced hospitalization risk with dupilumab in moderate-to-severe atopic dermatitis
User login
Username
Password
Reset your password
/content/reduced-hospitalization-risk-dupilumab-moderate-severe-atopic-dermatitis
/dermatology/article/252110/atopic-dermatitis/reduced-hospitalization-risk-dupilumab-moderate-severe